57.38% |
With copper(l) iodide; caesium carbonate; In dimethyl sulfoxide; at 120℃; for 24h;Inert atmosphere; |
Into a 250-mL round-bottom flask purged and maintained with an inert atmosphere of nitrogen, was placed N-[3-[(5-bromo-1-[[2- (trimethylsilyl)ethoxyj methylj -1 H-pyrrolo [2,3 -bjpyridin-6-yl)oxyj -4,4,4-trifluorobutylj -4- methylbenzene-1-sulfonamide (700 mg, 1.13 mmol, 1 equiv), Cs2CO3 (1.1 g, 3.39 mmol, 3.00 equiv), CuT (214 mg, 1.13 mmol,1.0 equiv), <strong>[39207-65-3]2-isobutyrylcyclohexan-1-one</strong> (80 mg, 0.56 mmol, 0.5 equiv), DMSO (10 mL), The resulting solution was stirred for 24 hr at 120 °C in an oil bath. The resulting solution was diluted with 20 mL of water. The resulting solution was extracted with 2 x 50 mL of ethyl acetate. The resulting mixture was washed with 1 x 50 mL of brine. The mixture was dried over anhydrous sodium sulfate and concentrated under vacuum. The residue was applied onto a silica gel column with ethyl acetate/petroleum ether (0-30percent). This resulted in 350 mg (57.38percent) of 1 -tosyl-4-(trifluoromethyl)-7-((2-(trimethylsilyl)ethoxy)methyl)- 1,3,4,7- tetrahydro-2H-pyrrolo[3?,2?:5,6jpyrido[2,3-bj[1,4joxazepine as light yellow solid. ?H NMR (300 MHz, CDCL3 ppm) 8.19 (bs, 1H), 7.50-7.47 (m, 2H), 7.39 (s, 1H), 7.24-7.22 (m, 2H), 6.58-6.57 (m, 1H), 5.69-5.66 (m, 1H), 5.55-5.5 1 (m, 1H), 4.57-4.52 (m, 1H), 3.96-3.94 (m, 1 H), 3.59-3.56 (m,2H), 3.48-3.44 (m, 1H), 2.41 (s, 3H), 2.3 1-2.29 (m, 1H), 1.95-1.91 (m, 1H), 0.97-0.91 (m, 2H), 0.05 (s, 9H). The measurements of the NMR spectra were done with Bruker Avancelli HD300MHz with a probe head of BBOF. |